Cost analysis and critical success factors of the use of oxygen concentrators versus cylinders in sub-divisional hospitals in Fiji.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
02 Jul 2021
Historique:
received: 25 11 2020
accepted: 23 06 2021
entrez: 3 7 2021
pubmed: 4 7 2021
medline: 7 7 2021
Statut: epublish

Résumé

Oxygen is vital in the treatment of illnesses in children and adults, yet is lacking in many low and middle-income countries health care settings. Oxygen concentrators (OCs) can increase access to oxygen, compared to conventional oxygen cylinders. We investigated the costs and critical success factors of OCs in three hospitals in Fiji, and extrapolated these to estimate the oxygen delivery cost to all Sub-Divisional hospitals (SDH) nationwide. Data sources included key personnel interviews, and data from SDH records, Ministry of Health and Medical Services, and a non-governmental organisation. We used Investment Logic Mapping (ILM) to define key issues. An economic case was developed to identify the investment option that optimised value while incorporating critical success factors identified through ILM. A fit-for-purpose analysis was conducted using cost analysis of four short-listed options. Sensitivity analyses were performed by altering variables to show the best or worst case scenario. All costs are presented in Fijian dollars. Critical success factors identifed included oxygen availability, safety, ease of use, feasibility, and affordability. Compared to the status quo of having only oxygen cylinders, an option of having a minimum number of concentrators with cylinder backup would cost $434,032 (range: $327,940 to $506,920) over 5 years which would be 55% (range: 41 to 64%) of the status quo cost. Introducing OCs into all SDHs in Fiji would reduce overall costs, while ensuring identified critical success factors are maintained. This study provides evidence for the benefits of OCs in this and similar settings.

Sections du résumé

BACKGROUND BACKGROUND
Oxygen is vital in the treatment of illnesses in children and adults, yet is lacking in many low and middle-income countries health care settings. Oxygen concentrators (OCs) can increase access to oxygen, compared to conventional oxygen cylinders. We investigated the costs and critical success factors of OCs in three hospitals in Fiji, and extrapolated these to estimate the oxygen delivery cost to all Sub-Divisional hospitals (SDH) nationwide.
METHODS METHODS
Data sources included key personnel interviews, and data from SDH records, Ministry of Health and Medical Services, and a non-governmental organisation. We used Investment Logic Mapping (ILM) to define key issues. An economic case was developed to identify the investment option that optimised value while incorporating critical success factors identified through ILM. A fit-for-purpose analysis was conducted using cost analysis of four short-listed options. Sensitivity analyses were performed by altering variables to show the best or worst case scenario. All costs are presented in Fijian dollars.
RESULTS RESULTS
Critical success factors identifed included oxygen availability, safety, ease of use, feasibility, and affordability. Compared to the status quo of having only oxygen cylinders, an option of having a minimum number of concentrators with cylinder backup would cost $434,032 (range: $327,940 to $506,920) over 5 years which would be 55% (range: 41 to 64%) of the status quo cost.
CONCLUSION CONCLUSIONS
Introducing OCs into all SDHs in Fiji would reduce overall costs, while ensuring identified critical success factors are maintained. This study provides evidence for the benefits of OCs in this and similar settings.

Identifiants

pubmed: 34215232
doi: 10.1186/s12913-021-06687-8
pii: 10.1186/s12913-021-06687-8
pmc: PMC8249838
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

636

Subventions

Organisme : Cure Kids
ID : 1612

Références

Int J Tuberc Lung Dis. 2004 Sep;8(9):1138-41
pubmed: 15455602
J Glob Health. 2020 Dec;10(2):020425
pubmed: 33274064
Cost Eff Resour Alloc. 2006 Aug 21;4:14
pubmed: 16923181
Int J Tuberc Lung Dis. 2009 May;13(5):587-93
pubmed: 19383191
PLoS Med. 2009 Nov;6(11):e1000137
pubmed: 19901978
Can J Anaesth. 2002 Jan;49(1):8-12
pubmed: 11782322
Bull World Health Organ. 2009 Oct;87(10):763-71
pubmed: 19876543
Lancet. 1996 Jun 8;347(9015):1597-9
pubmed: 8667871
Int Health. 2020 Jan 1;12(1):60-68
pubmed: 30916340
Int J Tuberc Lung Dis. 2010 Nov;14(11):1362-8
pubmed: 20937173
Bull World Health Organ. 2017 Apr 1;95(4):288-302
pubmed: 28479624
BMC Med Inform Decis Mak. 2018 Nov 1;18(1):90
pubmed: 30382826
BMJ Paediatr Open. 2017 Aug 31;1(1):e000083
pubmed: 29637121
Int J Tuberc Lung Dis. 2016 Aug;20(8):1130-4
pubmed: 27393551
Int J Tuberc Lung Dis. 2011 May;15(5):693-9
pubmed: 21756524
Lancet. 2008 Oct 11;372(9646):1328-33
pubmed: 18708248
PLoS One. 2014 Feb 20;9(2):e89872
pubmed: 24587089
Anaesthesia. 1991 Mar;46(3):217-9
pubmed: 2014901
Lancet Infect Dis. 2018 Nov;18(11):1191-1210
pubmed: 30243584
Bull World Health Organ. 2008 May;86(5):344-8
pubmed: 18545736
P N G Med J. 2010 Sep-Dec;53(3-4):126-38
pubmed: 23163183

Auteurs

Susan McAllister (S)

Centre for International Health, Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, PO Box 56, Dunedin, New Zealand. sue.mcallister@otago.ac.nz.

Louise Thorn (L)

Centre for International Health, Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, PO Box 56, Dunedin, New Zealand.

Sainimere Boladuadua (S)

Cure Kids Fiji, Suva, Fiji.
Department of Paediatrics: Child & Youth Health, University of Auckland, Auckland, New Zealand.

Mireia Gil (M)

Azimut 360 SCCL, Barcelona, Spain.

Rick Audas (R)

Faculty of Medicine, Memorial University of Newfoundland, St John's, Canada.

Tim Edmonds (T)

Cure Kids, Auckland, New Zealand.

Eric Rafai (E)

Ministry of Health and Medical Services, Suva, Fiji.

Philip C Hill (PC)

Centre for International Health, Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, PO Box 56, Dunedin, New Zealand.

Stephen R C Howie (SRC)

Department of Paediatrics: Child & Youth Health, University of Auckland, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH